Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
7 | 18227606 | intron variant | G/A | snv | 0.77 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
7 | 18196884 | intron variant | C/G | snv | 7.9E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 7 | 18872166 | intron variant | C/G | snv | 0.48 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.120 | 7 | 18723029 | intron variant | C/A | snv | 0.31 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.240 | 7 | 18658708 | intron variant | T/G | snv | 3.8E-02 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.120 | 7 | 18723029 | intron variant | C/A | snv | 0.31 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
7 | 18389298 | intron variant | A/G | snv | 2.9E-02 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
7 | 18629780 | intron variant | G/A | snv | 5.0E-03 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 7 | 18935100 | intron variant | T/G | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
7 | 18996297 | 3 prime UTR variant | T/A;C | snv |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
0.807 | 0.080 | 7 | 18838251 | intron variant | T/G | snv | 0.43 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.080 | 7 | 18857365 | intron variant | A/G | snv | 0.43 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.080 | 7 | 18857888 | intron variant | C/A;G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.040 | 7 | 18370370 | intron variant | A/C | snv | 1.4E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 7 | 18224045 | intron variant | A/T | snv | 0.61 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 7 | 18464885 | intron variant | G/A | snv | 0.96 |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
7 | 18814978 | intron variant | T/A | snv | 0.46 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
7 | 18797044 | intron variant | G/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
1.000 | 0.080 | 7 | 18245750 | intron variant | C/T | snv | 0.78 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 7 | 18935100 | intron variant | T/G | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 7 | 18591621 | missense variant | G/A | snv | 8.0E-06 | 1.4E-05 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.925 | 0.080 | 7 | 18644690 | missense variant | G/A;T | snv | 4.1E-05; 4.1E-06 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 7 | 18195234 | intron variant | T/C | snv | 3.9E-02 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 7 | 18992312 | intron variant | C/T | snv | 0.13 |
|
0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.882 | 0.120 | 7 | 18723029 | intron variant | C/A | snv | 0.31 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 |